Email : zhou@sinobiochemistry.com Phone : +86-13941198570
 |
| Quantity: | |
|---|---|
Boc-Lys(Boc)-OH
SINOBIO
29224999
Boc-Lys(Boc)-OH, assigned with CAS registry number 2483-46-7, is a high-purity double-protected lysine derivative tailored for pharmaceutical peptide synthesis. As a vital fine chemical intermediate in the biopharmaceutical industry, this high-grade protected amino acid adopts dual Boc group protection technology, which effectively avoids side reactions during peptide chain synthesis and greatly improves the yield and purity of finished peptide drugs.
Widely recognized as a core synthetic precursor for mainstream GLP-1 receptor agonist drugs, this compound is extensively utilized in the commercial production of popular hypoglycemic and weight-loss peptide pharmaceuticals. It is also a standard foundational building block for laboratory peptide research and customized peptide development, serving global pharmaceutical manufacturers, professional CDMO institutions and biotech R&D centers. With the continuous boom in the global anti-obesity and diabetes drug market, this high-quality peptide intermediate has maintained stable and growing market demand.
The application scenarios of Boc-Lys(Boc)-OH cover commercial drug mass production and scientific research and development, focusing on the GLP-1 drug track and solid-phase peptide synthesis field:
Special intermediate for the synthesis of classic weight-loss and anti-diabetic peptide drugs, including Semaglutide, Tirzepatide, Liraglutide and Lixisenatide, supporting the production of mainstream branded drugs such as Ozempic, Wegovy, Mounjaro and Zepbound.
As a key protected amino acid monomer, it is widely used in the customized synthesis of various therapeutic peptides, ensuring stable peptide chain connection and low impurity generation.
Ideal laboratory reagent for new drug screening, peptide structure optimization and pilot-scale production, supporting the technical research and project iteration of global biotech enterprises and scientific research institutions.
Applied to the preparation of high-purity active pharmaceutical ingredients of injectable peptide drugs, meeting the strict quality requirements of pharmaceutical-grade production.
Our Boc-Lys(Boc)-OH has stable export trade and serves high-quality customers in multiple regions worldwide. The core trading markets include Europe, North America, Asia-Pacific and emerging pharmaceutical markets, covering Germany, the United Kingdom, Switzerland, France, the United States, Canada, South Korea, Japan, India, Turkey, Israel, Singapore and Brazil. We provide one-stop raw material supply solutions for local pharmaceutical manufacturers, generic drug enterprises and scientific research institutions.
Driven by the global high incidence of obesity and type 2 diabetes, the GLP-1 peptide drug industry has ushered in explosive growth. As an irreplaceable key intermediate in the whole synthesis process of GLP-1 series drugs, Boc-Lys(Boc)-OH has rigid and sustainable market demand. Our high-quality and cost-effective products can help customers accelerate new drug R&D progress, reduce production costs and rapidly expand market share in the competitive GLP-1 drug track.
